The clinical trial conducted by Istanbul Bilgi University evaluates the efficacy of Nigella Sativa oil as a dietary supplement in managing hyperlipidemia among overweight adults. Given the rising prevalence of hyperlipidemia and associated cardiovascular diseases, this study could position Nigella Sativa oil as a viable natural alternative or adjunct to conventional pharmacological treatments. The results may enhance market interest in natural health products and dietary supplements, particularly in regions with high obesity and hyperlipidemia rates. Companies focusing on natural supplements may consider partnerships or product development based on the findings. The competitive landscape includes other natural products targeting lipid profiles, necessitating a thorough analysis of efficacy and safety profiles to differentiate offerings.